Explore

Discover daily Discover daily
How a Simple Plasma Molecule Redefined Skin Repair

How a Simple Plasma Molecule Redefined Skin Repair

Copper peptide GHK-Cu is a naturally occurring complex that has garnered attention for its significant role in wound healing. Found in human plasma...
Discover daily Discover daily
How Loren Pickart Discovered a Rejuvenating Peptide

How Loren Pickart Discovered a Rejuvenating Peptide

The copper peptide GHK-Cu, known for its wound healing and skin remodeling properties, has an intriguing history of discovery and development. This...
Trendline Trendline
Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Develop Oral Enzyme Therapy for Pancreatic Insufficiency

Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Develop Oral Enzyme Therapy for Pancreatic Insufficiency

Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Develop Oral Enzyme Therapy for Pancreatic Insufficiency
Trendline Trendline
enGene Reports Promising Interim Results for Bladder Cancer Gene Therapy Trial

enGene Reports Promising Interim Results for Bladder Cancer Gene Therapy Trial

enGene Reports Promising Interim Results for Bladder Cancer Gene Therapy Trial
Trendline Trendline
TRexBio Unveils Promising Data on TNFR2 Agonism for Atopic Dermatitis at Dermatology Meeting

TRexBio Unveils Promising Data on TNFR2 Agonism for Atopic Dermatitis at Dermatology Meeting

TRexBio Unveils Promising Data on TNFR2 Agonism for Atopic Dermatitis at Dermatology Meeting
Trendline Trendline
TRexBio Unveils Promising Data on TNFR2 Agonism for Atopic Dermatitis at SID Meeting

TRexBio Unveils Promising Data on TNFR2 Agonism for Atopic Dermatitis at SID Meeting

TRexBio Unveils Promising Data on TNFR2 Agonism for Atopic Dermatitis at SID Meeting
Trendline Trendline
Incyte Releases Positive 24-Week Data for Opzelura Cream in Atopic Dermatitis Treatment

Incyte Releases Positive 24-Week Data for Opzelura Cream in Atopic Dermatitis Treatment

Incyte Releases Positive 24-Week Data for Opzelura Cream in Atopic Dermatitis Treatment
Trendline Trendline
LTZ Therapeutics Secures $38 Million to Advance Immunotherapy Pipeline

LTZ Therapeutics Secures $38 Million to Advance Immunotherapy Pipeline

LTZ Therapeutics Secures $38 Million to Advance Immunotherapy Pipeline
Trendline Trendline
NImmune Biopharma Presents Promising Data for IBD Treatment at Digestive Disease Week

NImmune Biopharma Presents Promising Data for IBD Treatment at Digestive Disease Week

NImmune Biopharma Presents Promising Data for IBD Treatment at Digestive Disease Week
Trendline Trendline
Epicrispr and Forge Biologics Partner for AAV Manufacturing in Muscular Dystrophy Therapy

Epicrispr and Forge Biologics Partner for AAV Manufacturing in Muscular Dystrophy Therapy

Epicrispr and Forge Biologics Partner for AAV Manufacturing in Muscular Dystrophy Therapy
Trendline Trendline
Atossa Therapeutics' Endoxifen Trial Shows Promise in Reducing Breast Cancer Risk

Atossa Therapeutics' Endoxifen Trial Shows Promise in Reducing Breast Cancer Risk

Atossa Therapeutics' Endoxifen Trial Shows Promise in Reducing Breast Cancer Risk
Trendline Trendline
DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke

DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke

DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke